Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06814977 · ClinicalTrials.gov registry record · NA

An Acupuncture Study for Cancer Survivors With Joint Pain

A NA study of Cancer Survivor, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT06814977 is a NA study of Cancer Survivor that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 60 participants, below the 264-participant average among 25 other Cancer Survivor trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06814977, a NA study of Cancer Survivor, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

Conditions Studied

Interventions

  • PROCEDURE Acupuncture

Study Locations (2)

New York

  • Memorial Sloan Kettering Cancer Center (All protocol activites) - New York
  • Jamaica Hospital Medical Center - Richmond Hill

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-01-31
Est. Completion 2028-06-30
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT06814977

The ClinicalTrials.gov registry entry for NCT06814977 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 264-participant average among 25 other Cancer Survivor trials with a reported enrollment target (77% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer Survivor appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT06814977 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06814977 about?

NCT06814977 is a clinical study titled "An Acupuncture Study for Cancer Survivors With Joint Pain". The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

What is the current status of trial NCT06814977?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-01-31. Estimated completion is 2028-06-30.

What conditions does trial NCT06814977 study?

This clinical trial studies the following conditions: Cancer Survivor.

What interventions are being tested in trial NCT06814977?

The interventions under investigation include: Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT06814977?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06814977 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Survivor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.